LGND

Ligand Pharmaceuticals Incorporated (LGND)

About Ligand Pharmaceuticals Incorporated (LGND)

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.

Details

Daily high

$102.31

Daily low

$100.23

Price at open

$100.02

52 Week High

$112.12

52 Week Low

$49.24

Market cap

1.8B

Dividend yield

0.00%

Volume

20,926

Avg. volume

95,668

P/E ratio

43.40

Ligand Pharmaceuticals Incorporated News